Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Is there a need for additionalblood products in civilian health care for the therapeutic treatment of acute hemorrhage?
Örebro University, School of Medical Sciences.
2018 (English)Independent thesis Basic level (degree of Bachelor), 10 credits / 15 HE creditsStudent thesis
Abstract [en]

BackgroundNew military experiences of cryopreserved platelets and whole blood for the therapeutic treatment of acute hemorrhagehave led to an extensive academic debate on whether to include these blood products into civilian healthcare, where blood components and room temperature platelets serve as a one-size-fits-all productfor both prophylactic and therapeutic transfusions.PurposeTo evaluate the possible benefit ofother preparation methods of platelets, as well as whole blood, in civilian health care.MethodPlatelet transfusions of two Swedish counties were analyzed, and divided into three groups depending on which department that made the transfusion. One group for hematology and oncology departments/wards, one group for intensive care units(ICU), emergency departments(ED)and acute care wards(AC), and one group for all other departments/wards that made transfusions during the studied period. Each group was then divided into more specific categories.ResultsDepending on the region,7%-20% of all platelet transfusions were made in ICUs,5%-14% were made in surgical wardsand 1%-3% were made in ACs and EDs, and may be platelet transfusions madein conjunction with an active bleeding.44%-72% of all platelet transfusions were made in hematology departments/wards.ConclusionAccordingto this limited study, about 38% of all platelet transfusions in a county with a university hospital and 13% in a county without a university hospital, could benefit from transfusion with activated platelets, instead of those platelets that is today’s routine for prophylactic treatment.

Place, publisher, year, edition, pages
2018.
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:oru:diva-68278OAI: oai:DiVA.org:oru-68278DiVA, id: diva2:1235808
Subject / course
Medicine
Supervisors
Examiners
Available from: 2018-07-27 Created: 2018-07-27 Last updated: 2018-07-27Bibliographically approved

Open Access in DiVA

fulltext(1730 kB)4 downloads
File information
File name FULLTEXT01.pdfFile size 1730 kBChecksum SHA-512
5472a96ab04e2342e50b5f6deb3de543b92b32bd3541d276679aa44d8c460b54c1d07028be7e674f25ca2845d4c9338525bf2638a91670fdf13ac8507827d6b0
Type fulltextMimetype application/pdf

By organisation
School of Medical Sciences
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 4 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

urn-nbn

Altmetric score

urn-nbn
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf